Skip to main content
. 2021 Sep 13;42(3):457–467. doi: 10.1007/s00296-021-04965-6

Table 2.

Results of the outcome variables for the main study group of 1073 patients

All Patients Tocilizumab use P value
No Yes
N Row % N Col % N Col %
All Patients 1073 100.00 745 100.00 328 100.00
Outcome
 Others 957 100.00 685 91.95 272 82.93  < 0.0001
 Death/intubated 116 100.00 60 8.05 56 17.07
Intubation
 No 1005 100.00 705 94.63 300 91.46 0.0498
 Yes 68 100.00 40 5.37 28 8.54
Death
 No 1025 100.00 725 97.32 300 91.46  < 0.0001
 Yes 48 100.00 20 2.68 28 8.54